MDPI and ACS Style
Hou, Z.; Lin, S.; Du, T.; Wang, M.; Wang, W.; You, S.; Xue, N.; Liu, Y.; Ji, M.; Xu, H.;
et al. S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer. Pharmaceuticals 2023, 16, 749.
https://doi.org/10.3390/ph16050749
AMA Style
Hou Z, Lin S, Du T, Wang M, Wang W, You S, Xue N, Liu Y, Ji M, Xu H,
et al. S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer. Pharmaceuticals. 2023; 16(5):749.
https://doi.org/10.3390/ph16050749
Chicago/Turabian Style
Hou, Zhenyan, Songwen Lin, Tingting Du, Mingjin Wang, Weida Wang, Shen You, Nina Xue, Yichen Liu, Ming Ji, Heng Xu,
and et al. 2023. "S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer" Pharmaceuticals 16, no. 5: 749.
https://doi.org/10.3390/ph16050749